Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis.
Saved in:
| Title: | Long-term benefit from high-dose ifosfamide in sarcoma depends on sustained prior control and timely intervention: a machine learning analysis. |
|---|---|
| Authors: | Hoberger, Michael1 (AUTHOR), Zuber, Romy L.1 (AUTHOR), Burkhard-Meier, Anton1,2 (AUTHOR), Di Gioia, Dorit1 (AUTHOR), Jurinovic, Vindi1,3 (AUTHOR), Völkl, Michael1 (AUTHOR), Güler, Sinan E.1 (AUTHOR), Albertsmeier, Markus4 (AUTHOR), Klein, Alexander5 (AUTHOR), Dürr, Hans Roland5 (AUTHOR), Schmidt-Hegemann, Nina-Sophie6 (AUTHOR), Knösel, Thomas7 (AUTHOR), Kunz, Wolfgang G.2,8 (AUTHOR), von Bergwelt-Baildon, Michael1,2,9 (AUTHOR), Lindner, Lars H.1,2 (AUTHOR), Berclaz, Luc M.1,2,9 (AUTHOR) Luc.Berclaz@med.uni-muenchen.de |
| Source: | Journal of Cancer Research & Clinical Oncology. Jan2026, Vol. 152 Issue 1, p1-10. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
